Vasudev Jaiprakash Bailey - 23 Oct 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role: Director
Signature: /s/ Svai Sanford, Attorney-in-Fact
Issuer symbol: RANI
Transactions as of: 23 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 30 Oct 2025, 16:31:44 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bailey Vasudev Jaiprakash	Director	C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE	/s/ Svai Sanford, Attorney-in-Fact	30 Oct 2025	0002094741

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RANI	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	23 Oct 2025	Class A Common Stock	100,000	$2.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option will vest over a three-year period, with one-third of the shares subject to the option vesting on October 23, 2026, and one thirty-sixth of the shares subject to the option vesting each month thereafter, subject to the Reporting Person's continuous service with the Company through each vesting date.